Experience

Imugene Limited

• Australia
• Biotechnology Research
• 1 - 100 Employee

• Director, Translational Science

  • Aug 2023 - Present

  Durham, North Carolina, United States



Precision BioSciences, Inc.

• United States
• Biotechnology Research
• 100 - 200 Employee

• Director, Translational Science

  • Mar 2022 - Aug 2023

  Durham, North Carolina, United States

• Associate Director, Cell Therapy Discovery

  • Jan 2022 - Feb 2022

  Durham, North Carolina, United States

• Team Leader, Cell Therapy Discovery

  • Oct 2019 - Feb 2022

  Durham, NC, United States



Biogen

• United States
• Biotechnology Research
• 700 & Above Employee

• Scientist II, Bioassays, Analytical Development

  • Aug 2017 - Oct 2019

  RTP, NC

• Scientist I, Bioassays, Analytical Development

  • Oct 2013 - Jul 2017

  RTP, NC Expertise in: • Development and optimization of bioassay methods supporting process development • Statistical determination of suitability goalposts for binding assays • GMP method transfer • Automation development



Duke University Health System

• Hospitals and Health Care
• 700 & Above Employee

• Postdoctoral associate, Department of Medicine, Division of Cardiology

  • Jan 2009 - Oct 2013

  Durham, NC • Collaborated and liaised with an interdisciplinary team of scientists, clinicians, tissue engineers, and administrators across 3 labs at Duke and UNC to establish a novel area of research concerning microRNA-mediated cardiac reprogramming using both in vitro and in vivo models • Results published in Circulation Research represent the first report of microRNA-mediated cardiac reprogramming. • Project has since expanded to become a major focus in the Dzau laboratory at Duke.



Duke Translational Medicine Institute

• Regulatory Affairs Intern

  • Dec 2012 - Mar 2013

  Raleigh-Durham, North Carolina Area • Studied the IND process by analyzing documents sent to FDA and reviewing regulatory webcasts • Authored and reviewed a mock IND application using DTMI resources



Duke University

• United States
• Higher Education
• 700 & Above Employee

• Graduate student, Department of Pathology

  • 2002 - 2008

  Durham, NC • Contributed to the development of novel combinatorial methods for studying molecular alterations of the tumor vasculature. • Characterized a novel transgenic mouse model for the specific isolation of endothelial cell transcripts using RNP-tagging technology; model later utilized by other labs at Duke.



Johns Hopkins Medicine

• United States
• Hospitals and Health Care
• 700 & Above Employee

• Research Assistant, Institute of Genetic Medicine

  • 2000 - 2002

  Baltimore, Maryland Area • Assisted postdoctoral fellows and graduate students in a project investigating the loss of imprinting of IGF2 in Wilms’ tumor; results later published in Journal of the National Cancer Institute, 2001.



USDA, Foreign Disease Weed Science Research Unit

• Departmental Honors (Senior Thesis, Hood College)

  • Aug 1999 - Jun 2000

  Fort Detrick, Frederick, MD • Characterized and purified Myrobalan latent ringspot virus from infected plant tissue. • Results and analysis compiled for Departmental Honors thesis and presented at both internal and external meetings